Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Olopatadine studied for allergic conjunctivitis

Jan. 20, 1997

Acular approved in U.S. for postoperative ocular inflammation

Jan. 7, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Pilocarpine TDS shows antiglaucoma activity in patients

Jan. 2, 1997

Further approval for breakthrough glaucoma medication

Dec. 30, 1996

FDA ophthalmic devices committee meetings scheduled for January

Dec. 24, 1996

NIH offers anticataract invention for licensing

Dec. 20, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

VISX supplemental PMA slated for review

Dec. 12, 1996

InSite Vision completes preliminary clinical trial of ophthalmic drug candidate

Dec. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...